EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ZYUS Life Sciences's enterprise value is C$76.22 Mil.
ZYUS Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.35 Mil. Therefore, ZYUS Life Sciences's EV-to-Revenue for today is 217.15.
The historical rank and industry rank for ZYUS Life Sciences's EV-to-Revenue or its related term are showing as below:
TSXV:ZYUS'
s EV-to-Revenue Range Over the Past 10 Years
Min: 107.33 Med: 196.34 Max: 508.98
Current: 217.15
During the past 3 years, the highest EV-to-Revenue of ZYUS Life Sciences was 508.98. The lowest was 107.33. And the median was 196.34.
TSXV:ZYUS's EV-to-Revenue is ranked worse than 97.95% of 1024
companies
in the Drug Manufacturers industry
Industry Median: 2.285
vs TSXV:ZYUS: 217.15
The historical data trend for ZYUS Life Sciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ZYUS Life Sciences's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ZYUS Life Sciences's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where ZYUS Life Sciences's EV-to-Revenue falls into.
ZYUS Life Sciences's current Enterprise Value is C$76.22 Mil.
ZYUS Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZYUS Life Sciences (TSXV:ZYUS) EV-to-Revenue Explanation
ZYUS Life Sciences's share price for today is C$1.02.
ZYUS Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZYUS Life Sciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of ZYUS Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
ZYUS Life Sciences (TSXV:ZYUS) Business Description
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:ZYUS has been successfully added to your 